Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.

Revenue
+4.48%
EPS
+18.3%
Free cash flow
+33.0%
Total debt
−3.29%

Quarter to June 2026, against a year earlier

1,756.08 77.00 +4.59%
Market cap
$33.6B
P/E
37.6×
Fwd P/E
36.1×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a

Mettler-Toledo International, Inc. (MTD) Earnings & Analysis

Updated · Covers results through Q2 FY2026 · How this is made

Latest quarter

Mettler-Toledo reported Q2 FY2026 revenue of $1.0 billion, up 4.48% from $983.2 million in Q2 FY2025. The company’s revenue was 0.46% below the consensus, which also rounded to $1.0 billion. Mettler-Toledo reported adjusted EPS, as the consensus counts it, of $11.46 versus the $10.78 consensus, or 6.31% above it, while diluted EPS was $11.55, up 18.3% from $9.76.

The filing says organic local-currency sales increased 4%, with laboratory sales up 4%, industrial sales up 3%, and service sales up 7%. Mettler-Toledo said organic local-currency revenue rose 1% in the Americas, 4% in Europe and 9% in Asia/Rest of World, including 9% growth in China. Gross margin was 63.3%, compared with 59.0%, and operating margin was 30.6%, compared with 27.0%. The company reported free cash flow of $282.6 million, compared with $212.5 million a year earlier.

Q2 FY2026 Q2 FY2025 Change
Revenue $1.0 billion $983.2 million 4.48%
Diluted EPS $11.55 $9.76 18.3%
Gross margin 63.3% 59.0% 4.3 percentage points
Operating margin 30.6% 27.0% 3.6 percentage points
Free cash flow $282.6 million $212.5 million 33.0%
Against the consensus Reported Consensus Result
Adjusted EPS $11.46 $10.78 Beat by 6.31%
Revenue $1.0 billion $1.0 billion In line

Adjusted EPS is the figure the consensus estimates, not the GAAP EPS above.

What management said on the call

No transcript or other record of Mettler-Toledo’s latest earnings call is available. The company’s filing said Q2 organic local-currency sales growth included process analytics, laboratory balances and analytical instruments, while core industrial growth also contributed.

The filing attributed gross-profit improvement, excluding one-time tariff-related U.S. government and customer refunds, to favorable price realization, lower tariff costs and benefits from its SternDrive program; unfavorable foreign currency and higher transportation costs partly offset those items. Mettler-Toledo also said its local-currency selling, general and administrative expense increase included sales and marketing investments, partly offset by cost-savings initiatives. The filing did not provide call-based analyst questions, responses, or management commentary on the quarter ahead.

Guidance

Mettler-Toledo forecasts Q3 FY2026 non-GAAP EPS of $12.00–$12.15. The company also expects Q3 FY2026 local-currency sales to increase approximately 4%. The available company guidance does not identify a previous outlook for comparison.

Metric For Guide Previous guide Change
EPS, non-GAAP Q3 FY2026 $12.00–$12.15 — New